Thrombectomy in stroke of unknown onset, wake up stroke and late presentations: Australian experience from 2 comprehensive stroke centres.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 13 06 2018
accepted: 27 10 2018
pubmed: 12 11 2018
medline: 14 2 2019
entrez: 12 11 2018
Statut: ppublish

Résumé

Two recent randomized controlled trials (RCTs) showed selected patients treated with endovascular thrombectomy (EVT) more than 6 h from acute ischemic stroke (AIS) onset had significant improvement in functional outcome at 90 days compared with standard care alone. Our aim is to determine the outcome and predictors of good outcome in AIS patients undergoing EVT with unknown-onset, or late presentation, stroke after 6 h from time last seen well, or witnessed stroke onset, at two Australian comprehensive stroke centres. A retrospective analysis of functional outcome and mortality at 90-days from a prospective cohort of 56 consecutive patients with unknown-onset, or late presentation, stroke with large vessel occlusion (LVO) in the anterior cerebral circulation undergoing EVT over a 15-month period (2016-2017). We evaluated factors which correlated with good functional outcome defined as a 90-day modified Rankin scale (mRS) 0-2. Recanalization times and symptomatic intracranial haemorrhage (sICH) rates were also examined. A good functional outcome was achieved in 35 patients (62%). Eight patients died (14%). Median time-to-recanalization was 7.6 h. SICH occurred in four patients (7%). Factors which predicted good 90-day functional outcome included baseline National Institutes of Health Stroke Scale (NIHSS) < 16, 24 h NIHSS < 10, baseline Alberta Stroke Program Early CT Score (ASPECTS) ≥ 8, pre-procedural CT perfusion imaging and LVO lesion location. This study shows good 'real world' outcomes, comparable to published RCTs, in patients with unknown-onset, or late presentation, stroke treated with EVT more than 6 h from stroke onset.

Identifiants

pubmed: 30414809
pii: S0967-5868(18)31028-2
doi: 10.1016/j.jocn.2018.10.114
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-140

Informations de copyright

Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Auteurs

Khalid Alsahli (K)

Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Australia; Prince of Wales Hospital Clinical School, University of New South Wales, Australia.

Andrew K Cheung (AK)

Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Australia; Department of Interventional Neuroradiology, Liverpool Hospital, Liverpool, Australia; Ingham Institute for Applied Medical Research, Sydney, Australia.

Nirupama Wijesuriya (N)

Ingham Institute for Applied Medical Research, Sydney, Australia; Department of Neurology and Neurophysiology, Liverpool Hospital, Liverpool, Australia.

Dennis Cordato (D)

Ingham Institute for Applied Medical Research, Sydney, Australia; Department of Neurology and Neurophysiology, Liverpool Hospital, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Australia.

Alessandro S Zagami (AS)

Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Australia; Prince of Wales Hospital Clinical School, University of New South Wales, Australia.

Jason D Wenderoth (JD)

Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Australia; Prince of Wales Hospital Clinical School, University of New South Wales, Australia; Department of Interventional Neuroradiology, Liverpool Hospital, Liverpool, Australia; Ingham Institute for Applied Medical Research, Sydney, Australia.

Albert H Chiu (AH)

Institute of Neurological Sciences, Prince of Wales Hospital, Randwick, Australia; Prince of Wales Hospital Clinical School, University of New South Wales, Australia; Department of Interventional Neuroradiology, Liverpool Hospital, Liverpool, Australia.

Kevin Tay (K)

Medical Imaging Department, Prince of Wales Hospital, Randwick, Australia.

Cecilia Cappelen-Smith (C)

Ingham Institute for Applied Medical Research, Sydney, Australia; Department of Neurology and Neurophysiology, Liverpool Hospital, Liverpool, Australia; South Western Sydney Clinical School, University of New South Wales, Australia. Electronic address: Cecilia.CappelenSmith@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH